HIV Clinical Trial
— TextITOfficial title:
Texting to Improve Testing (TextIT): A Cluster Randomized Stepped Wedge Trial of Text Messaging to Improve Postpartum Retention in Care and Early Infant Diagnosis of HIV
Verified date | November 2017 |
Source | University of Washington |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Early accurate diagnosis is one of the first crucial steps in care for infants born to
HIV-infected mothers. Early initiation of antiretroviral therapy (ART) relies upon early
diagnosis and results in significant reductions in infant morbidity and mortality. The
investigators recently concluded a successful randomized controlled trial in Kenya entitled,
"Improving uptake of early infant diagnosis of HIV for prevention of mother-to-child HIV
transmission (PMTCT): a randomized trial of a text messaging intervention"
(ClinicalTrials.gov # NCT01433185). In this study, text messages developed using a behavioral
theoretical framework significantly improved maternal attendance at post-partum clinic
appointments and rates of testing to facilitate early infant diagnosis of HIV in a selected
population and controlled setting. Understanding the effectiveness of this intervention (and
its limitations) in a real-world, routine-care setting represents the next step in the
translational pathway to public health impact. The investigators therefore now propose a
cluster randomized, stepped wedge trial in 20 clinics operated by the Kenyan Ministry of
Health in the Nyanza region of Kenya and use the Reach, Effectiveness, Adoption,
Implementation, and Maintenance (REAIM) framework to understand the effectiveness of the text
messaging to improve testing (TextIT) intervention. Our specific aims are:
1. To determine the effect of TextIT on maternal attendance at postpartum clinic visits
during the randomized stepped-wedge rollout of the intervention.
Hypothesis 1: A greater proportion of women at health facilities implementing TextIT
will attend clinic within eight weeks postpartum compared to women at health facilities
implementing standard care.
2. To determine the effect of TextIT on virological infant HIV testing within eight weeks
after birth during the randomized stepped-wedge rollout of the intervention.
Hypothesis 2: Infants of women at health facilities implementing TextIT will be more
likely to have virological HIV testing compared to infants of women at health facilities
implementing standard care.
3. To determine the costs and cost-effectiveness of TextIT. The investigators will estimate
the cost per patient and per health gain achieved (disability-adjusted life year, DALY)
comparing TextIT to current standard care.
Hypothesis 3: The TextIT intervention will be more cost-effective than current standard care.
Status | Active, not recruiting |
Enrollment | 2508 |
Est. completion date | December 2018 |
Est. primary completion date | December 2017 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 14 Years and older |
Eligibility |
Inclusion Criteria: - Are =18 years or emancipated minors; - Are at 28 weeks gestation or greater (or have delivered on the day of enrollment); - Provide informed consent Exclusion Criteria: - Women who report sharing phones but have not disclosed their HIV status to the person with whom the phone is shared. |
Country | Name | City | State |
---|---|---|---|
Kenya | Kenya Medical Research Institute, Family AIDS Care and Education Services | Kisumu | Nyanza |
Lead Sponsor | Collaborator |
---|---|
University of Washington | University of California, San Francisco |
Kenya,
Odeny TA, Bukusi EA, Cohen CR, Yuhas K, Camlin CS, McClelland RS. Texting improves testing: a randomized trial of two-way SMS to increase postpartum prevention of mother-to-child transmission retention and infant HIV testing. AIDS. 2014 Sep 24;28(15):2307-12. doi: 10.1097/QAD.0000000000000409. — View Citation
Odeny TA, Newman M, Bukusi EA, McClelland RS, Cohen CR, Camlin CS. Developing content for a mHealth intervention to promote postpartum retention in prevention of mother-to-child HIV transmission programs and early infant diagnosis of HIV: a qualitative study. PLoS One. 2014 Sep 2;9(9):e106383. doi: 10.1371/journal.pone.0106383. eCollection 2014. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Postpartum retention in prevention of mother-to-child HIV transmission programs | Maternal attendance at postpartum clinic visits within eight weeks after delivery | 1 year | |
Primary | Infant HIV testing by DNA PCR within 8 weeks after birth | 1 year | ||
Primary | Cost-effectiveness of TextIT | 1 year | ||
Secondary | Overall public health impact | To determine the overall public health impact of the TextIT strategy using the REAIM framework which assesses five dimensions of public health interventions: Reach, Effectiveness, Adoption, Implementation, and Maintenance | 1 year | |
Secondary | Place of delivery and skilled birth attendance | 1 year | ||
Secondary | A combined outcome for stillbirth (after 28 weeks of pregnancy) or infant death within the first two months after a live birth | 1 year | ||
Secondary | Birth weight | 1 year | ||
Secondary | Reported infant feeding option | 1 year | ||
Secondary | Incidence rate of HIV-1 among infants who undergo virological HIV testing | 1 year | ||
Secondary | 18 month PMTCT outcomes | Includes discharge from the PMTCT program, referral and linkage to the general HIV comprehensive care clinic, transfer out to another health facility, lost to follow-up or death; and infant HIV status by antibody testing. | 18 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06162897 -
Case Management Dyad
|
N/A | |
Completed |
NCT03999411 -
Smartphone Intervention for Smoking Cessation and Improving Adherence to Treatment Among HIV Patients
|
Phase 4 | |
Completed |
NCT02528773 -
Efficacy of ART to Interrupt HIV Transmission Networks
|
||
Active, not recruiting |
NCT05454839 -
Preferences for Services in a Patient's First Six Months on Antiretroviral Therapy for HIV in South Africa
|
||
Recruiting |
NCT05322629 -
Stepped Care to Optimize PrEP Effectiveness in Pregnant and Postpartum Women
|
N/A | |
Completed |
NCT02579135 -
Reducing HIV Risk Among Adolescents: Evaluating Project HEART
|
N/A | |
Active, not recruiting |
NCT01790373 -
Evaluating a Youth-Focused Economic Empowerment Approach to HIV Treatment Adherence
|
N/A | |
Not yet recruiting |
NCT06044792 -
The Influence of Primary HIV-1 Drug Resistance Mutations on Immune Reconstruction in PLWH
|
||
Completed |
NCT04039217 -
Antiretroviral Therapy (ART) Persistence in Different Body Compartments in HIV Negative MSM
|
Phase 4 | |
Active, not recruiting |
NCT04519970 -
Clinical Opportunities and Management to Exploit Biktarvy as Asynchronous Connection Key (COMEBACK)
|
N/A | |
Completed |
NCT04124536 -
Combination Partner HIV Testing Strategies for HIV-positive and HIV-negative Pregnant Women
|
N/A | |
Recruiting |
NCT05599581 -
Tu'Washindi RCT: Adolescent Girls in Kenya Taking Control of Their Health
|
N/A | |
Active, not recruiting |
NCT04588883 -
Strengthening Families Living With HIV in Kenya
|
N/A | |
Completed |
NCT02758093 -
Speed of Processing Training in Adults With HIV
|
N/A | |
Completed |
NCT02500446 -
Dolutegravir Impact on Residual Replication
|
Phase 4 | |
Completed |
NCT03805451 -
Life Steps for PrEP for Youth
|
N/A | |
Active, not recruiting |
NCT03902431 -
Translating the ABCS Into HIV Care
|
N/A | |
Completed |
NCT00729391 -
Women-Focused HIV Prevention in the Western Cape
|
Phase 2/Phase 3 | |
Recruiting |
NCT05736588 -
Elimisha HPV (Human Papillomavirus)
|
N/A | |
Recruiting |
NCT03589040 -
Darunavir and Rilpivirine Interactions With Etonogestrel Contraceptive Implant
|
Phase 2 |